Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Finished Product Quality Assurance

Posted on By

SOP for Finished Product Quality Assurance

Standard Operating Procedure for Finished Product Quality Assurance

1) Purpose

This SOP outlines the procedures for ensuring the quality of finished pharmaceutical products before they are released for distribution to ensure they meet all regulatory and company quality standards.

2) Scope

This SOP applies to all finished products manufactured within the company that are ready for final testing, review, and release.

3) Responsibilities

The Quality Assurance (QA) department is responsible for implementing and maintaining this SOP. The QA team ensures that all finished products meet specified quality criteria before release.

See also  Quality Assurance: SOP for Documentation Control in Gels Production

4) Procedure

4.1 Final Product Testing

  1. Collect samples of the finished product as per the sampling plan.
  2. Send samples to the Quality Control (QC) laboratory for final testing according to predefined specifications, including potency, purity, dissolution, and other relevant tests.
  3. Document all test results in the laboratory information management system (LIMS).

4.2 Batch Review

  1. Review the Batch Production Record (BPR) to ensure all manufacturing steps were completed as per the approved procedures.
  2. Verify that all in-process controls and critical quality attributes (CQAs) meet the specified criteria.

4.3 Acceptance or Rejection

  1. Compare the final product test results against predefined specifications to determine compliance.
  2. Approve the batch for release if it passes all tests and meets all quality criteria.
  3. Reject the batch
if it fails any test or does not meet the criteria, quarantine it, and initiate an investigation report.

4.4 Documentation and Release

  1. Complete all necessary documentation, including the Certificate of Analysis (COA) and Quality Assurance Release Form.
  2. Authorize the release of the batch for distribution after all documentation is reviewed and approved.
  3. Ensure that all records are stored securely and are easily accessible for audits and inspections.

5) Abbreviations, if any

QA: Quality Assurance
QC: Quality Control
LIMS: Laboratory Information Management System
BPR: Batch Production Record
CQA: Critical Quality Attribute
COA: Certificate of Analysis

6) Documents, if any

Batch Production Records, Certificates of Analysis, Quality Assurance Release Forms, Test Result Records, Investigation Reports

7) Reference, if any

Regulatory guidelines such as FDA, EMA, ICH Q6A (Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances), and ICH Q10 (Pharmaceutical Quality System)

8) SOP Version

Version 1.0

See also  Quality Assurance: SOP for Use of Gelling Agents in Gels Production
Quality Assurance Tags:Batch Record Review SOP, CAPA SOP (Corrective and Preventive Actions), Change Control Management SOP, Cleaning Validation SOP, Documentation Control SOP, Equipment Qualification SOP, Finished Product Quality Assurance, Good Documentation Practices SOP, Handling Deviations SOP, In-process Quality Control SOP, Internal Quality Audits SOP, Out-of-Specification SOP, Packaging Material Quality Control, Pharmaceutical quality assurance SOP, Process Validation SOP, Product Complaint Handling SOP, Product Recall Management SOP, Quality Assurance Audits SOP, Quality Control Sample Management, Quality Risk Management SOP, Serialization and Traceability SOP, SOP for Raw Material Quality Assurance, Supplier Qualification SOP, Training and Competency Assessment SOP, Vendor Audits SOP

Post navigation

Previous Post: SOP for Loss on Drying Testing
Next Post: Injectables: SOP for Documentation and Record Keeping

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version